Isabella Pickering

Ms. Isabella Pickering

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 November 2021 in JMIR Mental Health
Verified
Journal Article
Open access
KLKate Loveys
Kate Loveys
MSMark Sagar
Mark Sagar
IPIsabella Pickering
Isabella Pickering
EBElizabeth Anne Broadbent
Elizabeth Anne Broadbent
Background: Loneliness is a growing public health issue that has been exacerbated in vulnerable groups during the COVID-19 pandemic. Computer agents are capable of delivering psychological therapies through the internet; however, there is limited research on their acceptability to date. Objective: The objectives of this study were to evaluate (1) the feasibility and acceptability of a remote loneliness and stress intervention with digital human delivery to at-risk adults and (2) the feasibility of the study methods in preparation for a randomized controlled trial. Methods: A parallel randomized pilot trial with a mixed design was conducted. Participants were adults aged 18 to 69 years with an underlying medical condition or aged 70 years or older with a Mini-Mental State Examination score of >24 (ie, at greater risk of developing severe COVID-19). Participants took part from their place of residence (independent living retirement village, 20; community dwelling, 7; nursing home, 3). Participants were randomly allocated to the intervention or waitlist control group that received the intervention 1 week later. The intervention involved completing cognitive behavioral and positive psychology exercises with a digital human facilitator on a website for at least 15 minutes per day over 1 week. The exercises targeted loneliness, stress, and psychological well-being. Feasibility was evaluated using dropout rates and behavioral observation data. Acceptability was evaluated from behavioral engagement data, the Friendship Questionnaire (adapted), self-report items, and qualitative questions. Psychological measures were administered to evaluate the feasibility of the trial methods and included the UCLA Loneliness Scale, the 4-item Perceived Stress Scale, a 1-item COVID-19 distress measure, the Flourishing Scale, and the Scale of Positive and Negative Experiences. Results: The study recruited 30 participants (15 per group). Participants were 22 older adults and 8 younger adults with a health condition. Six participants dropped out of the study. Thus, the data of 24 participants were analyzed (intervention group, 12; waitlist group, 12). The digital human intervention and trial methods were generally found to be feasible and acceptable in younger and older adults living independently, based on intervention completion, and behavioral, qualitative, and some self-report data. The intervention and trial methods were less feasible to nursing home residents who required caregiver assistance. Acceptability could be improved with additional content, tailoring to the population, and changes to the digital human’s design. Conclusions: Digital humans are a promising and novel technological solution for providing at-risk adults with access to remote psychological support during the COVID-19 pandemic. Research should further examine design techniques to improve their acceptability in this application and investigate intervention effectiveness in a randomized controlled trial. Trial Registration: Australia New Zealand Clinical Trials Registry ACTRN12620000786998; https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=380113

30 January 2025 in Psychology & Health
Verified
Journal Article
Open access
IPIsabella Pickering
Isabella Pickering
MLMikaela Law
Mikaela Law
SCStefan Calder
Stefan Calder
GOGreg O’GRady
Greg O’GRady
EBElizabeth Anne Broadbent
Elizabeth Anne Broadbent
Cognitive behavioural therapy (CBT) has shown efficacy in improving mental health and symptoms of functional dyspepsia (FD), a prevalent disorder of gut-brain interaction (DGBI). However, FD-specific CBT is not widely available or scalable. Therefore, this study explored the perspectives of patients with FD and clinicians who treat them on the use of digital CBT-based interventions. This qualitative study involved semi-structured interviews with 21 patients with FD and 10 clinicians. Iterative, inductive thematic analysis was conducted. Three patient themes were developed: (1) their experiences contributing to coping difficulties, emphasising the complexity of self-management; (2) a desire for more personalised options, highlighting the need for accessible, FD-tailored CBT; and (3) concerns regarding human contact, safety, usability, and data security. Four clinician themes were also developed: (1) digital CBT bridges a gap in psychological support within gastroenterology; (2) perceived clinical utility of CBT; (3) digital CBT allows patient self-management; and (4) clinical concerns, including symptom tracking and patient safety. Both patients and clinicians recognised the value and utility of digital CBT for FD. Tailored, digital CBT could inform and improve current management, making FD-specific psychological support more accessible.

29 July 2025 in medRxiv
Verified
Preprint
Open access
PDF file
MLMikaela Law
Mikaela Law
Gabriel SchambergGabriel Schamberg
Gabriel Schamberg
CVChris Varghese
Chris Varghese
BWBilly Wu
Billy Wu
CDCharlotte Daker
Charlotte Daker
GOGregory O'Grady
Gregory O'Grady
Background and aims: Chronic gastroduodenal symptoms may be associated with psychological factors; however, recent evidence suggests these associations vary by previously undetermined disease factors. Body surface gastric mapping (BSGM) is a non-invasive diagnostic method integrating high-resolution myoelectrical measurement and validated symptom profiling. This cross-sectional study investigated associations between psychological factors and BSGM phenotypes. Methods: Patients from the general community meeting the Rome IV Criteria for functional dyspepsia or chronic nausea and vomiting syndrome underwent BSGM using Gastric Alimetry ® . The test protocol included a 30-min fasting baseline, 482 kCal meal, and 4-hr postprandial recording. Measures of depression, anxiety, stress, and quality of life were assessed at baseline, and symptoms were logged throughout the test. BSGM phenotypes were classified using established rule-based criteria. Results: Among 278 patients (mean age 39.5, 15-88; 77% female), clinical diagnoses of depression (45%) and anxiety (46%) were common. Depression, anxiety, and stress measures were positively associated with symptom severity; however, these associations varied substantially by BSGM phenotype. Abnormal rhythm stability predicted higher depression ( B =0.35, p =.044) and stress ( B =1.48, p =.026). Among patients with normal spectral metrics, continuous symptoms predicted higher levels of depression ( B =0.42, p =.003), anxiety ( B =0.30, p =.045), and stress ( B =1.43, p =.008), and worse quality of life ( B =-0.57, p < .001); while sensorimotor symptoms predicted higher anxiety ( B =0.46, p =.029) and worse quality of life ( B =-0.49, p =.033). Conclusion: This study confirms significant connections between gastroduodenal symptoms and mental health, but refines these associations to specific BSGM phenotypes. Individuals exhibiting normal spectral metrics alongside continuous or sensorimotor symptoms may particularly benefit from integrated psychological interventions.

6 June 2025 in medRxiv
Verified
Preprint
Open access
PDF file
MLMikaela Law
Mikaela Law
GHGayl Humphrey
Gayl Humphrey
IPIsabella Pickering
Isabella Pickering
Gabriel SchambergGabriel Schamberg
Gabriel Schamberg
CVChris Varghese
Chris Varghese
SCStefan Calder
Stefan Calder
Background: Chronic gastroduodenal symptoms present significant challenges for young people, often negatively impacting their quality of life and mental health. However, there is currently a lack of validated tools to assess mental health in young people with chronic gastroduodenal symptoms. This research outlines the development and validation of the Alimetry® Gut-Brain Wellbeing Survey-Youth Version (AGBW-Y), a novel tool for assessing mental health in young people with chronic gastroduodenal symptoms aged 12-17 years. Methods: An iterative multi-phase approach was employed. In Phase 1, feedback was gathered from 19 paediatric clinicians in the gastroenterology field and 33 young people over multiple rounds to adapt the adult version of the AGBW Survey to be age-appropriate for young people aged 12-17 years. In Phase 2, rigorous psychometric testing of the adapted scale was conducted in a sample of 128 patients aged 12-17 years with chronic gastroduodenal symptoms, using an anonymous online survey. Results: Based on the feedback from Phase 1, an interdisciplinary team of experts improved the survey’s language and usability for young people, including the removal of reverse-coded items. These adjustments enhanced the scale’s clarity, acceptability, and face and content validity. The final AGBW-Y comprises a patient preface, an opt-out option, 10 closed-ended questions, and an optional open-ended question. It assesses general mental health, alongside subscales of depression, stress, and anxiety. Phase 2 demonstrated excellent psychometric properties of the scale, including high internal consistency (α= .91 for the total scale; α= .75-.85 for subscales) and strong convergent, divergent, and concurrent validity with large effect sizes. Conclusions: The AGBW-Y is a brief, reliable, and valid tool to assess mental health in young people with chronic gastroduodenal symptoms. This novel scale was developed through a rigorous co-design process with clinicians and young people, ensuring it is contextually relevant and clinically impactful. The AGBW-Y complements existing physiological assessments, enabling more accurate mental health evaluations which can be used to guide psychological referrals, support multidisciplinary care, and evaluate treatment outcomes.

26 August 2026 in medRxiv
Verified
Preprint
Open access
PDF file
MLMikaela Law
Mikaela Law
IPIsabella Pickering
Isabella Pickering
NDNicky Dachs
Nicky Dachs
Gabriel SchambergGabriel Schamberg
Gabriel Schamberg
CDCharlotte Daker
Charlotte Daker
SCStefan Calder
Stefan Calder
Introduction: Illness perceptions, the cognitive and emotional beliefs patients hold about their condition, are key determinants of patient outcomes across a range of chronic health conditions. Although well-studied in several gastrointestinal disorders, their role remains poorly characterized within patients with functional dyspepsia (FD) and chronic nausea and vomiting syndrome (CNVS). This study examined the associations between illness perceptions, gastrointestinal symptoms, mental health, and gastric electrophysiology in these patients. Methods: Patients meeting self-reported Rome IV criteria for FD and/or CNVS underwent body surface gastric mapping (BSGM) using Gastric Alimetry (Alimetry, New Zealand). The standardized protocol included a 30-minute fasting baseline, 482 kCal meal, and a 4-hour postprandial recording, with concurrent symptom logging. From the BSGM data, patients were phenotyped using established rule-based criteria via the Auckland Classification. Illness perceptions were assessed using the Brief Illness Perceptions Questionnaire alongside validated psychological and quality of life metrics. Results: The cohort included 309 patients (80% female; median age= 36, 15-88) who reported highly negative illness perceptions, which were significantly correlated with worse symptomatology, quality of life, and mental health (medium-large effect sizes). Using multivariable analysis, perceived consequences and emotional responses emerged as the most robust predictors of these patient-reported outcomes. Additionally, illness perceptions significantly mediated the relationship between mental health and gastrointestinal symptoms, with large effect sizes. Associations with gastric electrophysiology were limited to BMI-Adjusted Amplitude, which was associated with poorer perceptions of treatment control and greater emotional response to symptoms. Furthermore, the Continuous Phenotype (normal spectral activity, with continuous symptoms) was associated with worse illness perceptions, including higher perceived consequences, symptom identity, concern, and emotional response, whilst the High Frequency Phenotype was associated with lower understanding. Discussion: The way patients perceive their condition is a quantifiable aspect of the illness experience that is associated with symptom burden, mental health, and quality of life in patients with FD and CNVS. The observed associations with gastric electrophysiology suggest that illness perceptions may also vary in relation to underlying patient physiology. These findings support the consideration of illness perceptions as part of multidisciplinary assessment and management, including targeted patient education and clinical interventions to address distressing or maladaptive illness beliefs.

26 June 2021 in JMIR Preprints
Verified
Preprint
Open access
KLKate Loveys
Kate Loveys
MSMark Sagar
Mark Sagar
IPIsabella Pickering
Isabella Pickering
EBElizabeth Anne Broadbent
Elizabeth Anne Broadbent
BACKGROUND Loneliness is a growing public health issue that has been exacerbated in vulnerable groups during the COVID-19 pandemic. Computer agents are capable of delivering psychological therapies through the internet; however, there is limited research on their acceptability to date. OBJECTIVE The objectives of this study were to evaluate (1) the feasibility and acceptability of a remote loneliness and stress intervention with digital human delivery to at-risk adults and (2) the feasibility of the study methods in preparation for a randomized controlled trial. METHODS A parallel randomized pilot trial with a mixed design was conducted. Participants were adults aged 18 to 69 years with an underlying medical condition or aged 70 years or older with a Mini-Mental State Examination score of >24 (ie, at greater risk of developing severe COVID-19). Participants took part from their place of residence (independent living retirement village, 20; community dwelling, 7; nursing home, 3). Participants were randomly allocated to the intervention or waitlist control group that received the intervention 1 week later. The intervention involved completing cognitive behavioral and positive psychology exercises with a digital human facilitator on a website for at least 15 minutes per day over 1 week. The exercises targeted loneliness, stress, and psychological well-being. Feasibility was evaluated using dropout rates and behavioral observation data. Acceptability was evaluated from behavioral engagement data, the Friendship Questionnaire (adapted), self-report items, and qualitative questions. Psychological measures were administered to evaluate the feasibility of the trial methods and included the UCLA Loneliness Scale, the 4-item Perceived Stress Scale, a 1-item COVID-19 distress measure, the Flourishing Scale, and the Scale of Positive and Negative Experiences. RESULTS The study recruited 30 participants (15 per group). Participants were 22 older adults and 8 younger adults with a health condition. Six participants dropped out of the study. Thus, the data of 24 participants were analyzed (intervention group, 12; waitlist group, 12). The digital human intervention and trial methods were generally found to be feasible and acceptable in younger and older adults living independently, based on intervention completion, and behavioral, qualitative, and some self-report data. The intervention and trial methods were less feasible to nursing home residents who required caregiver assistance. Acceptability could be improved with additional content, tailoring to the population, and changes to the digital human’s design. CONCLUSIONS Digital humans are a promising and novel technological solution for providing at-risk adults with access to remote psychological support during the COVID-19 pandemic. Research should further examine design techniques to improve their acceptability in this application and investigate intervention effectiveness in a randomized controlled trial. CLINICALTRIAL Australia New Zealand Clinical Trials Registry ACTRN12620000786998; https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=380113